Cargando…
Development and Characterization of Oral Raft Forming In Situ Gelling System of Neratinib Anticancer Drug Using 3(2) Factorial Design
Neratinib (NTB) is an irreversible inhibitor of pan-human epidermal growth factor receptor (HER-2) tyrosine kinase and is used in the treatment of breast cancer. It is a poorly aqueous soluble drug and exhibits extremely low oral bioavailability at higher pH, leading to a diminishing of the therapeu...
Autores principales: | Hani, Umme, Rahamathulla, Mohamed, Osmani, Riyaz Ali M., Begum, M.Yasmin, Wahab, Shadma, Ghazwani, Mohammed, Fatease, Adel Al, Alamri, Ali H., Gowda, Devegowda V., Alqahtani, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269124/ https://www.ncbi.nlm.nih.gov/pubmed/35808569 http://dx.doi.org/10.3390/polym14132520 |
Ejemplares similares
-
Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy
por: Hani, Umme, et al.
Publicado: (2022) -
Carvedilol Precipitation Inhibition by the Incorporation of Polymeric Precipitation Inhibitors Using a Stable Amorphous Solid Dispersion Approach: Formulation, Characterization, and In Vitro In Vivo Evaluation
por: Ravikumar, Akhila Akkihebbal, et al.
Publicado: (2022) -
Development and Evaluation of Solid Lipid Nanoparticles for the Clearance of Aβ in Alzheimer’s Disease
por: Shivananjegowda, Meghana Goravinahalli, et al.
Publicado: (2023) -
Anti-Proliferative Potential of Quercetin Loaded Polymeric Mixed Micelles on Rat C6 and Human U87MG Glioma Cells
por: Paranthaman, Sathishbabu, et al.
Publicado: (2022) -
Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation
por: Begum, M. Yasmin, et al.
Publicado: (2022)